B.Riley Financial analyst Mayank Mamtani has maintained their bullish stance on NVAX stock, giving a Buy rating on November 13.Don't Miss our ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

The stock market's "Trump bump" that followed his victory over Vice President Kamala Harris in last week's election appears ...

Health-care companies fell sharply as the selection of Robert F. Kennedy Jr. as Donald Trump's nominee to head the Department of Health and Human Services weighed on vaccine makers. Shares of Pfizer, ...

Shares of Novavax Inc. NVAX rose 1.39% to $7.32 Friday, on what proved to be an all-around rough trading session for the ...

Trump previously said RFK Jr. would have carte blanche to "go wild" on health-related matters if he became part of Trump's ...

Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX ...

Remember when everyone was excited the stock market spiked after Trump’s election win? Well, turns out it was very short-lived.

The stocks for three pharmaceutical companies heavily involved in the production of vaccines fell drastically by market close ...

Companies that make immunizations bore the brunt of the losses, with Moderna Inc., Pfizer Inc. and Novavax Inc. all falling ...